Top Markets
#1 Islamic Coin Islamic Coin +151.37%
#2 Black Phoenix Black Phoenix +35.44%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +20.25%
#4 Akedo Akedo +16.37%
#5 Fake World Assets Fake World Assets +13.93%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.22%
#7 clBTC clBTC +11.99%
#8 HOME HOME +11.30%
#9 Arowana Arowana +10.18%
#10 OpenEden OpenEden +8.72%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Nabriva Therapeutics plc Nabriva Therapeutics plc

Nabriva Therapeutics plc

NBRV
Classificação em ações #39979
Nabriva Therapeutics plc is a biopharmaceutical company focused on the... Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.
Preço da ação
$0.63
Última sincronização: 2023-08-29
Valor de mercado
$284.20K
Variação (1 dia)
-21.25%
Variação (1 ano)
0.00%
País
IE
Negociar Nabriva Therapeutics plc (NBRV)

Categoria

Healthcare
Histórico de preços das ações de Nabriva Therapeutics plc (NBRV)
Preço de fecho mais alto: $0.72 em 2023-08-01

Preço de fecho mais baixo: $2.65K em 2015-09-01
Histórico de preços das ações da Nabriva Therapeutics plc de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 -62.69%
2022 -88.16%
2021 -77.92%
2020 -82.12%
2019 -3.21%
2018 -70.79%
2017 19.90%
2016 -48.03%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.15%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE